bioRxivCell Biology
Generation of inducible SMARCAL1 knock-down iPSC to model severe Schimke immune-osseous dysplasia reveals a link between replication stress and altered expression of master differentiation genes
G. M. Pugliese, F. Salaris, V. Palermo, V. Marabitti, N. Morina, A. Rosa, A. Franchitto, P. Pichierri
Abstract
The Schimke immuno-osseous dysplasia is an autosomal recessive genetic osteochondrodysplasia characterized by dysmorphism, spondyloepiphyseal dysplasia, nephrotic syndrome and frequently T cell immunodeficiency. Several hypotheses have been proposed to explain pathophysiology of the disease, however, the mechanism by which SMARCAL1 mutations cause the syndrome is elusive. Indeed, animal models of the disease are absent or useless to provide insight into the disease mechanism, since they do not recapitulate the phenotype. We generated a conditional knockdown model of SMARCAL1 in iPSCs to mimic conditions of cells with severe form the disease. Here, we characterize this model for the presence of phenotype linked to the replication caretaker role of SMARCAL1 using multiple cellular endpoints. Our data show that conditional knockdown of SMARCAL1 in human iPSCs induces replication-dependent and chronic accumulation of DNA damage triggering the DNA damage response. Furthermore, they indicate that accumulation of DNA damage and activation of the DNA damage response correlates with increased levels of R-loops and replication-transcription interference. Finally, we provide data showing that, in SMARCAL1-deficient iPSCs, DNA damage response can be maintained active also after differentiation, possibly contributing to the observed altered expression of a subset of germ layer-specific master genes. In conclusion, our conditional SMARCAL1 iPSCs may represent a powerful model where studying pathogenetic mechanisms of severe Schimke immuno-osseous dysplasia, thus overcoming the reported inability of different model systems to recapitulate the disease.
- organism: human
- assay: scRNA-seq
- assay: DNA methylation
- research focus: cell type annotation
- research focus: differential expression
- research focus: chromatin & epigenetic regulation
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- An iPSC-based iMSC Model for Osteogenesis Imperfecta: A Platform for Disease Modeling and Drug Screening
Ashis Kumar, Vignesh Kumar, … Vasanth Thamodaran·bioRxiv·Jun 11, 2025
- Human iPSC-derived muscle cells as a new model for investigation of EDMD1 pathogenesis.
Marta Lisowska, Marta Rowińska, … Katarzyna Piekarowicz·International Journal of Molecular SciencesPeer-reviewed·Feb 12, 2025
- iPSC-derived skeletal muscle spheroids for Duchenne Muscular Dystrophy modeling
Joyce Esposito, Felipe de Souza Leite, … Mayana Zatz·Skeletal MusclePeer-reviewed·May 2, 2026
- Skeletal muscle cells derived from induced pluripotent stem cells: a platform for limb girdle muscular dystrophies.
c. Bruge, M. GEOFFROY, … X. Nissan·bioRxiv·May 8, 2022
- GSK3 inhibition rescues growth and telomere dysfunction in dyskeratosis congenita iPSC-derived type II alveolar epithelial cells
R. J. Fernandez, Z. J. G. Gardner, … F. B. Johnson·bioRxiv·Oct 28, 2020
- Engineered SMCHD1 and D4Z4 mutations reveal roles of D4Z4 heterochromatin disruption and feedforward DUX4 network activation in FSHD
Xiangduo Kong, Nam Viet Nguyen, … Kyoko Yokomori·bioRxiv·Oct 14, 2022